These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy. Akers KS; Cota JM; Chung KK; Renz EM; Mende K; Murray CK J Burn Care Res; 2012; 33(6):e254-62. PubMed ID: 22878490 [TBL] [Abstract][Full Text] [Related]
28. Estimation of glomerular filtration rate to adjust vancomycin dosage in critically ill patients: superiority of the Chronic Kidney Disease Epidemiology Collaboration equation? Conil JM; Georges B; Breden A; Ruiz S; Cougot P; Fourcade O; Saivin S Anaesth Intensive Care; 2014 Mar; 42(2):178-84. PubMed ID: 24580382 [TBL] [Abstract][Full Text] [Related]
29. Getting the dose of vancomycin right in the neonate. van den Anker JN Int J Clin Pharmacol Ther; 2011 Apr; 49(4):247-9. PubMed ID: 21429437 [No Abstract] [Full Text] [Related]
30. New Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients. Cristallini S; Hites M; Kabtouri H; Roberts JA; Beumier M; Cotton F; Lipman J; Jacobs F; Vincent JL; Creteur J; Taccone FS Antimicrob Agents Chemother; 2016 Aug; 60(8):4750-6. PubMed ID: 27216073 [TBL] [Abstract][Full Text] [Related]
31. Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia. Hochart C; Berthon C; Corm S; Gay J; Cliquennois M; Tricot S; Alfandari S Med Mal Infect; 2011 Dec; 41(12):652-6. PubMed ID: 22056376 [TBL] [Abstract][Full Text] [Related]
32. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application. Tafelski S; Nachtigall I; Troeger U; Deja M; Krannich A; Günzel K; Spies C; J Infect Public Health; 2015; 8(4):355-63. PubMed ID: 25794497 [TBL] [Abstract][Full Text] [Related]
33. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration. Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847 [TBL] [Abstract][Full Text] [Related]
34. Vancomycin levels: to draw or not to draw. Creekmore F S D J Med; 1998 Jun; 51(6):195-6. PubMed ID: 9646718 [No Abstract] [Full Text] [Related]
35. Prediction of distribution volume of vancomycin in critically ill patients using extravascular lung water and pulmonary vascular permeability indices. Imaura M; Yokoyama H; Kohyama T; Nagafuchi H; Kohata Y; Takahashi H; Yamada Y Int J Clin Pharmacol Ther; 2012 Nov; 50(11):814-20. PubMed ID: 22943925 [TBL] [Abstract][Full Text] [Related]
36. Comment: assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Goutelle S; Neely M; Bleyzac N Ann Pharmacother; 2011 Sep; 45(9):1171-2. PubMed ID: 21862712 [No Abstract] [Full Text] [Related]
37. Vancomycin dosing nomograms targeting high serum trough levels in different populations: pros and cons. Elyasi S; Khalili H Eur J Clin Pharmacol; 2016 Jul; 72(7):777-88. PubMed ID: 27117446 [TBL] [Abstract][Full Text] [Related]
38. Vancomycin clearance in high-volume venovenous hemofiltration. Paciullo CA; Harned KC; Davis GA; Connor MJ; Winstead PS Ann Pharmacother; 2013 Mar; 47(3):e14. PubMed ID: 23404801 [TBL] [Abstract][Full Text] [Related]
39. Antibiotic therapy of methicillin-resistant Staphylococcus aureus in critical care. Tverdek FP; Crank CW; Segreti J Crit Care Clin; 2008 Apr; 24(2):249-60, vii-viii. PubMed ID: 18361944 [TBL] [Abstract][Full Text] [Related]